Marketing-authorisation holder · Canada
Avir Pharma Inc.
22 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
22 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN INJECTION10 mg / ml · Solution | Paracetamol | Canada | Marketed | 2019 |
| BACLOFEN INTRATHECAL0.5 mg / ml · Solution | Baclofen | Canada | Marketed | 2021 |
| BACLOFEN INTRATHECAL2 mg / ml · Solution | Baclofen | Canada | Marketed | 2021 |
| BACLOFEN INTRATHECAL0.05 mg / ml · Solution | Baclofen | Canada | Not marketed | 2022 |
| BIVALIRUDIN INJECTION5 mg / ml · Solution | Bivalirudin | Canada | Marketed | 2021 |
| CRESEMBA100 mg · Capsule | Isavuconazole | Canada | Marketed | 2019 |
| CRESEMBA40 mg · Capsule | Isavuconazole | Canada | Marketed | 2025 |
| CRESEMBA200 mg / vial · Powder For Solution | Isavuconazole | Canada | Marketed | 2019 |
| JORVEZA1 mg · Tablet (Orally-Disintegrating) | Budesonide | Canada | Marketed | 2021 |
| JORVEZA0.5 mg · Tablet (Orally-Disintegrating) | Budesonide | Canada | Marketed | 2021 |
| LEVOTHYROXINE SODIUM FOR INJECTION500 mcg / vial · Powder For Solution | Levothyroxine | Canada | Marketed | 2018 |
| LEVOTHYROXINE SODIUM FOR INJECTION200 mcg / vial · Powder For Solution | Levothyroxine | Canada | Marketed | 2019 |
| MEZERA500 mg · Tablet (Delayed-Release) | Mesalazine | Canada | Marketed | 2022 |
| MEZERA1 g / act · Foam | Mesalazine | Canada | Marketed | 2018 |
| MEZERA1 G · Suppository | Mesalazine | Canada | Marketed | 2018 |
| MEZERA1 G · Tablet (Delayed-Release) | Mesalazine | Canada | Marketed | 2024 |
| ONAKTA1 % / w/w · Ointment | Tirbanibulin | Canada | Authorised | |
| OSNUVO250 mcg / ml · Solution | Teriparatide | Canada | Marketed | 2020 |
| SINCALIDE FOR INJECTION5 mcg / vial · Powder For Solution | Sincalide | Canada | Marketed | 2023 |
| SUGAMMADEX100 mg / ml · Solution | Sugammadex | Canada | Authorised | |
| ZEVTERA500 mg / vial · Powder For Solution | Ceftobiprole medocaril | Canada | Marketed | 2018 |
| GADOPENTETATE DIMEGLUMINE INJECTION469 mg / ml · Solution | Gadopentetic acid | Canada | Cancelled |